These results indicate that silencing of RASSF3 by promoter methylation is ubiquitous in pituitary somatotroph adenomas, and might be an early event in somatotroph adenoma tumorigenesis. This evidence concerns the gene RASSF3 and growth hormone secreting pituitary adenoma 1.